What are the major opportunities in the mRNA Cancer Vaccines And Therapeutics market? What are the strategies for the mRNA Cancer Vaccines And Therapeutics market?

For detailed insights on the major opportunities and strategies in the mRNA Cancer Vaccines And Therapeutics market, Read More

How does the mRNA Cancer Vaccines And Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on mRNA Cancer Vaccines And Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the mRNA Cancer Vaccines And Therapeutics market growth? SWOT analysis of the mRNA Cancer Vaccines And Therapeutics market.

For detailed insights on the key dynamics influencing the mRNA Cancer Vaccines And Therapeutics market growth and SWOT analysis of the mRNA Cancer Vaccines And Therapeutics industry, Read More

mRNA Cancer Vaccines And Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

mRNA Cancer Vaccines And Therapeutics Market Report 2026

Name: mRNA Cancer Vaccines And Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Cancer, Other Applications), By End User (Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

mRNA Cancer Vaccines And Therapeutics Market Overview

• mRNA Cancer Vaccines And Therapeutics market size has reached to $71.22 billion in 2025

• Expected to grow to $141.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%

• Growth Driver: The Rise In Cancer Prevalence Fueling The Growth Of The Market Due To Increasing Lifestyle-Related And Environmental Risk Factors

• Market Trend: Innovative Personalized Cancer Vaccines Aim To Boost Immune Response And Improve Survival In High-Risk Melanoma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under mRNA Cancer Vaccines And Therapeutics Market?

mRNA cancer vaccines and therapeutics refer to a type of medical treatment that utilizes messenger RNA (mRNA) to stimulate the immune system to recognize and fight cancer cells. It is used to deliver instructions to cells to produce therapeutic proteins or enzymes and help prime the immune system to identify and destroy cancer cells that express these antigens.

The main mRNA cancer vaccines and therapeutics types are adeno carcinomas, mucinous carcinomas, and adenosquamous carcinomas. Adeno carcinomas refers to a type of cancer that forms in mucus-secreting glands throughout the body. It is applied for infectious disease, cancer, and others and it is used by several end users such as hospitals and clinics, ambulatory surgical centers, research institutes, and others.

mRNA Cancer Vaccines And Therapeutics Market Global Report 2026 Market Report bar graph

What Is The mRNA Cancer Vaccines And Therapeutics Market Size and Share 2026?

The mrna cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $71.22 billion in 2025 to $82.67 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to success of mrna platforms in infectious disease vaccines, advancements in cancer immunology research, increasing understanding of tumor antigens, early clinical validation of mrna cancer therapies, growing public and private funding for oncology innovation.

What Is The mRNA Cancer Vaccines And Therapeutics Market Growth Forecast?

The mrna cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $141.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising global cancer burden, growing demand for personalized and targeted cancer treatments, expansion of mrna manufacturing capacity, increasing number of oncology clinical trials using mrna platforms, strategic collaborations between biotech and pharmaceutical companies. Major trends in the forecast period include rising adoption of personalized cancer vaccines, expansion of mrna-based therapeutics beyond oncology, growing focus on neoantigen-specific vaccine development, increased clinical pipeline for mrna cancer immunotherapies, higher investment in scalable mrna manufacturing platforms.

Book your 30 minutes free consultation with our research experts

Global mRNA Cancer Vaccines And Therapeutics Market Segmentation

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

What Is The Driver Of The mRNA Cancer Vaccines And Therapeutics Market?

The rising prevalence of cancer is expected to propel the growth of the mRNA cancer vaccine and therapeutic market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells that can invade and damage healthy tissues. The increasing incidence of cancer is largely attributed to factors such as sedentary lifestyles, poor dietary habits, and exposure to environmental toxins, all of which elevate the risk of developing various malignancies. mRNA cancer vaccines and therapeutics play a crucial role in advancing cancer treatment by enabling personalized, targeted immune responses that help the body identify and eliminate cancer cells more effectively, thereby improving treatment outcomes. For instance, in January 2024, according to the American Cancer Society, Inc., a US-based cancer advocacy organization in 2024, the United States is expected to witness over 611,000 cancer-related deaths, averaging more than 1,600 fatalities per day. Therefore, the rising prevalence of cancer is driving the growth of the mRNA cancer vaccine and therapeutic market.

Key Players In The Global mRNA Cancer Vaccines And Therapeutics Market

Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)

Global mRNA Cancer Vaccines And Therapeutics Market Trends and Insights

Major companies operating in the mRNA cancer vaccines and therapeutics market are focusing on developing innovative solutions, such as personalized neoantigen vaccines, to enhance immune response and improve survival outcomes in cancer patients. Personalized neoantigen vaccines are cancer therapies designed for each patient, using unique tumor-specific mutations to stimulate the immune system to target and destroy cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, partnered with Moderna Therapeutics, Inc., a US-based biotechnology company, to initiate a Phase 3 randomized clinical trial (V940-001) to evaluate mRNA-4157 (V940) in combination with KEYTRUDA (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This study follows positive results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which showed a meaningful benefit of the combination over KEYTRUDA alone in reducing recurrence and distant metastasis risk. The Phase 3 trial aims to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as primary and secondary endpoints, respectively.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market?

In June 2025 BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed amount. With the acquisition, BioNTech SE aims to strengthen the research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapy candidates, marking a key milestone in its oncology strategy to advance innovative cancer treatments and establish new standards of care in the coming years. CureVac N.V. is a Germany-based company that develops mRNA-based cancer vaccines and therapies.

Regional Insights

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the mRNA Cancer Vaccines And Therapeutics Market?

mRNA cancer vaccines and therapeutics market consists of sales of individualized cancer treatment mRNA vaccine, infectious disease treatment mRNA vaccine, and infection prevention mRNA vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the mRNA Cancer Vaccines And Therapeutics Market Report 2026?

The mrna cancer vaccines and therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mrna cancer vaccines and therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

mRNA Cancer Vaccines And Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$82.67 billion
Revenue Forecast In 2035	$141.51 billion
Growth Rate	CAGR of 16.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak Bio
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. mRNA Cancer Vaccines And Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global mRNA Cancer Vaccines And Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. mRNA Cancer Vaccines And Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Cancer Vaccines

4.2.2 Expansion Of Mrna-Based Therapeutics Beyond Oncology

4.2.3 Growing Focus On Neoantigen-Specific Vaccine Development

4.2.4 Increased Clinical Pipeline For Mrna Cancer Immunotherapies

4.2.5 Higher Investment In Scalable Mrna Manufacturing Platforms

5. mRNA Cancer Vaccines And Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Ambulatory Surgical Centers

5.3 Cancer Treatment Centers

5.4 Academic And Clinical Research Institutes

5.5 Biotechnology And Pharmaceutical Research Facilities

6. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global mRNA Cancer Vaccines And Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global mRNA Cancer Vaccines And Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global mRNA Cancer Vaccines And Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global mRNA Cancer Vaccines And Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. mRNA Cancer Vaccines And Therapeutics Market Segmentation

9.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

9.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cancer, Other Applications

9.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

9.4. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

9.5. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

9.6. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

10. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis

10.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market

11.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China mRNA Cancer Vaccines And Therapeutics Market

12.1. China mRNA Cancer Vaccines And Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India mRNA Cancer Vaccines And Therapeutics Market

13.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan mRNA Cancer Vaccines And Therapeutics Market

14.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview

14.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia mRNA Cancer Vaccines And Therapeutics Market

15.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia mRNA Cancer Vaccines And Therapeutics Market

16.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea mRNA Cancer Vaccines And Therapeutics Market

17.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview

17.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan mRNA Cancer Vaccines And Therapeutics Market

18.1. Taiwan mRNA Cancer Vaccines And Therapeutics Market Overview

18.2. Taiwan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia mRNA Cancer Vaccines And Therapeutics Market

19.1. South East Asia mRNA Cancer Vaccines And Therapeutics Market Overview

19.2. South East Asia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe mRNA Cancer Vaccines And Therapeutics Market

20.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview

20.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK mRNA Cancer Vaccines And Therapeutics Market

21.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany mRNA Cancer Vaccines And Therapeutics Market

22.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France mRNA Cancer Vaccines And Therapeutics Market

23.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy mRNA Cancer Vaccines And Therapeutics Market

24.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain mRNA Cancer Vaccines And Therapeutics Market

25.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market

26.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview

26.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia mRNA Cancer Vaccines And Therapeutics Market

27.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America mRNA Cancer Vaccines And Therapeutics Market

28.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview

28.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA mRNA Cancer Vaccines And Therapeutics Market

29.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview

29.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada mRNA Cancer Vaccines And Therapeutics Market

30.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview

30.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America mRNA Cancer Vaccines And Therapeutics Market

31.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview

31.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil mRNA Cancer Vaccines And Therapeutics Market

32.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East mRNA Cancer Vaccines And Therapeutics Market

33.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview

33.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa mRNA Cancer Vaccines And Therapeutics Market

34.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview

34.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. mRNA Cancer Vaccines And Therapeutics Market Regulatory and Investment Landscape

36. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles

36.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. mRNA Cancer Vaccines And Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. mRNA Cancer Vaccines And Therapeutics Market Company Profiles

36.3.1. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Moderna Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. CureVac N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Immatics Biotechnologies GmbH Overview, Products and Services, Strategy and Financial Analysis

37. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies

Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)

38. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market

40. mRNA Cancer Vaccines And Therapeutics Market High Potential Countries, Segments and Strategies

40.1 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global mRNA Cancer Vaccines And Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global mRNA Cancer Vaccines And Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global mRNA Cancer Vaccines And Therapeutics Market, Supply Chain Analysis

Table 4: Global mRNA Cancer Vaccines And Therapeutics Market, Major Raw Material Providers

Table 5: Global mRNA Cancer Vaccines And Therapeutics Market, Major Resource Providers

Table 6: Global mRNA Cancer Vaccines And Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global mRNA Cancer Vaccines And Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global mRNA Cancer Vaccines And Therapeutics Market, Key Technologies & Future Trends

Table 9: Global mRNA Cancer Vaccines And Therapeutics Market, Major Trends

Table 10: Global mRNA Cancer Vaccines And Therapeutics Market, Major End Users

Table 11: Global mRNA Cancer Vaccines And Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global mRNA Cancer Vaccines And Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global mRNA Cancer Vaccines And Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global mRNA Cancer Vaccines And Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global mRNA Cancer Vaccines And Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global mRNA Cancer Vaccines And Therapeutics Market - Company Scoring Matrix

Table 97: BioNTech SE Financial Performance

Table 98: Moderna Therapeutics Inc. Financial Performance

Table 99: CureVac N.V. Financial Performance

Table 100: Arcturus Therapeutics Holdings Inc. Financial Performance

Table 101: Immatics Biotechnologies GmbH Financial Performance

Table 102: Global mRNA Cancer Vaccines And Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 103: Global mRNA Cancer Vaccines And Therapeutics Market, Competitive Dashboard

Table 104: Global mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 107: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global mRNA Cancer Vaccines And Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global mRNA Cancer Vaccines And Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global mRNA Cancer Vaccines And Therapeutics Market, Supply Chain Analysis

Figure 4: Global mRNA Cancer Vaccines And Therapeutics Market, Major Raw Material Providers

Figure 5: Global mRNA Cancer Vaccines And Therapeutics Market, Major Resource Providers

Figure 6: Global mRNA Cancer Vaccines And Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global mRNA Cancer Vaccines And Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global mRNA Cancer Vaccines And Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global mRNA Cancer Vaccines And Therapeutics Market, Major Trends

Figure 10: Global mRNA Cancer Vaccines And Therapeutics Market, Major End Users

Figure 11: Global mRNA Cancer Vaccines And Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global mRNA Cancer Vaccines And Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global mRNA Cancer Vaccines And Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global mRNA Cancer Vaccines And Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global mRNA Cancer Vaccines And Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global mRNA Cancer Vaccines And Therapeutics Market - Company Scoring Matrix

Figure 97: BioNTech SE Financial Performance

Figure 98: Moderna Therapeutics Inc. Financial Performance

Figure 99: CureVac N.V. Financial Performance

Figure 100: Arcturus Therapeutics Holdings Inc. Financial Performance

Figure 101: Immatics Biotechnologies GmbH Financial Performance

Figure 102: Global mRNA Cancer Vaccines And Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global mRNA Cancer Vaccines And Therapeutics Market, Competitive Dashboard

Figure 104: Global mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 107: Global, mRNA Cancer Vaccines And Therapeutics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cervical Cancer Vaccine Market Report 2026 - Global Outlook – By Type (Cervarix, Gardasil, Gardasil 9), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-Users (Hospital, Other ...

RNA Targeting Small Molecules Therapeutics Market Report 2026 - Global Outlook – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonuclei...

Swine Vaccines Market Report 2026 - Global Outlook – By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines), By Disease (Viral Infections...

mRNA Cancer Vaccines And Therapeutics Market Report 2026 - Global Outlook – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Cancer, Other Applications), By End User (Hospitals A...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

mRNA Therapeutics Market Report 2026 - Global Outlook – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals...

Dendritic Cell Cancer Vaccine Market Report 2026 - Global Outlook – By Product (CreaVax, Sipuleucel-T (Provenge), Other Products), By Distribution Channel (Hospitals, Cancer Centers, Ambulatory Surgical Centers, Clinics)...

Frequently Asked Questions

How big is the mRNA Cancer Vaccines And Therapeutics Market?

The mRNA Cancer Vaccines And Therapeutics market was valued at $71.22 billion in 2025, increased to $82.67 billion in 2026, and is projected to reach $141.51 billion by 2030. request a sample here

What is the mRNA Cancer Vaccines And Therapeutics market growth?

The global mRNA Cancer Vaccines And Therapeutics market is expected to grow at a CAGR of 14.4% from 2026 to 2035 to reach $141.51 billion by 2035. request a sample here

Who are the key players in mRNA Cancer Vaccines And Therapeutics market?

Some Key Players in the mRNA Cancer Vaccines And Therapeutics market Include, BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG) . request a sample here

What is the anticipated growth trend for the mRNA Cancer Vaccines And Therapeutics market?

Major trend in this market includes: Innovative Personalized Cancer Vaccines Aim To Boost Immune Response And Improve Survival In High-Risk Melanoma. For further insights on this market. request a sample here

Which region has the most growth potential in the mRNA Cancer Vaccines And Therapeutics market?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the mRNA Cancer Vaccines And Therapeutics Market Report 2026 market?

Major companies operating in the mRNA Cancer Vaccines And Therapeutics Market Report 2026 market are Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therap request a sample here.